Tyra Biosciences reported earnings of -$ 0.74 per TYRA share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.67 |
| Earnings Per Share (Surprise) | -$ 0.74 (-$ 0.07) |
| Last Year's EPS | -$ 0.50 |
| EPS YoY Change |
Out of the last 27 earnings reporting periods, Tyra Biosciences beat analysts’ expectations 9 times and fell short of expectations 11 time(s). Tyra Biosciences reported earnings per share of -$ 0.74 in the last report falling to reach an estimated EPS of -$ 0.67 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.67 | -$ 0.74 | -$ 0.50 | |
| Aug 4, 2026 | -$ 0.65 | -$ 0.69 | -$ 0.47 | |
| May 13, 2026 | -$ 0.60 | -$ 0.64 | -$ 0.47 | |
| Mar 2, 2026 | -$ 0.54 | -$ 0.57 | -$ 0.43 | |
| Nov 5, 2025 | -$ 0.50 | -$ 0.50 | -$ 0.41 | |
| Aug 14, 2025 | -$ 0.53 | -$ 0.47 | -$ 0.32 | |
| May 8, 2025 | -$ 0.49 | -$ 0.47 | -$ 0.35 | |
| Mar 27, 2025 | -$ 0.48 | -$ 0.43 | -$ 0.53 | |
| Nov 7, 2024 | -$ 0.40 | -$ 0.41 | -$ 0.49 | |
| Aug 7, 2024 | -$ 0.41 | -$ 0.32 | -$ 0.31 | |
| May 9, 2024 | -$ 0.46 | -$ 0.35 | -$ 0.28 | |
| Mar 19, 2024 | -$ 0.48 | -$ 0.53 | -$ 0.31 | |
| Nov 7, 2023 | -$ 0.35 | -$ 0.49 | -$ 0.30 | |
| Aug 10, 2023 | -$ 0.34 | -$ 0.31 | -$ 0.36 | |
| May 4, 2023 | -$ 0.37 | -$ 0.28 | -$ 0.36 | |
| Mar 22, 2023 | -$ 0.35 | -$ 0.31 | -$ 0.24 | |
| Nov 3, 2022 | -$ 0.41 | -$ 0.30 | -$ 0.72 | |
| Aug 4, 2022 | -$ 0.33 | -$ 0.36 | -$ 0.19 | |
| May 5, 2022 | -$ 0.20 | -$ 0.36 | -$ 0.15 | |
| Mar 3, 2022 | -$ 0.21 | -$ 0.24 | -$ 0.16 |
Tyra Biosciences’s stock was trading at $ 22.30 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, TYRA’s price decreased to $ 20.97 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.74 | $ 22.30 | $ 20.97 | |
| Aug 4, 2026 | -$ 0.69 | $ 32.04 | $ 25.71 | |
| May 13, 2026 | -$ 0.64 | $ 34.87 | $ 36.51 | |
| Mar 2, 2026 | -$ 0.57 | $ 33.31 | $ 33.01 | |
| Nov 5, 2025 | -$ 0.50 | $ 15.00 | $ 14.28 | |
| Aug 14, 2025 | -$ 0.47 | $ 10.75 | $ 10.73 | |
| May 8, 2025 | -$ 0.47 | $ 9.13 | $ 10.09 | |
| Mar 27, 2025 | -$ 0.43 | $ 10.24 | $ 9.77 | |
| Nov 7, 2024 | -$ 0.41 | $ 17.12 | $ 16.11 | |
| Aug 7, 2024 | -$ 0.32 | $ 20.20 | $ 20.34 | |
| May 9, 2024 | -$ 0.35 | $ 18.03 | $ 17.35 | |
| Mar 19, 2024 | -$ 0.53 | $ 16.23 | $ 17.37 | |
| Nov 7, 2023 | -$ 0.49 | $ 12.80 | $ 12.00 | |
| Aug 10, 2023 | -$ 0.31 | $ 15.25 | $ 15.39 | |
| May 4, 2023 | -$ 0.28 | $ 12.85 | $ 12.42 | |
| Mar 22, 2023 | -$ 0.31 | $ 15.97 | $ 15.45 | |
| Nov 3, 2022 | -$ 0.30 | $ 7.00 | $ 6.50 | |
| Aug 4, 2022 | -$ 0.36 | $ 9.33 | $ 10.37 | |
| May 5, 2022 | -$ 0.36 | $ 8.94 | $ 8.95 | |
| Mar 3, 2022 | -$ 0.24 | $ 11.95 | $ 10.57 |
Tyra Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Tyra Biosciences missed analysts’ expectations during the last earnings period by
